XML 31 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash Flows from Operating Activities      
Net income (loss) $ (6,812) $ (1,563) $ 941
Adjustments to reconcile net income (loss) to net cash provided by operating activities      
Depreciation, depletion, and amortization 4,603 4,550 3,927
Deferred income taxes (3,177) (147) 137
Dry hole expense and impairments of unproved properties 2,267 1,245 864
Impairments 5,075 836 794
(Gains) losses on divestitures, net 1,022 (1,891) 470
Total (gains) losses on derivatives, net (100) 207 (392)
Operating portion of net cash received (paid) in settlement of derivative instruments 335 371 85
Other 320 327 246
Changes in assets and liabilities      
(Increase) decrease in accounts receivable (2) 103 719
Increase (decrease) in accounts payable and accrued expenses (995) 97 148
Other items, net 772 (71) 146
Net cash provided by (used in) operating activities (1,877) 8,466 8,888
Cash Flows from Investing Activities      
Additions to properties and equipment and dry hole costs (6,067) (9,508) (7,721)
Acquisition of businesses (3) (1,527) (473)
Divestitures of properties and equipment and other assets 1,415 4,968 567
Other, net (116) (405) (589)
Net cash provided by (used in) investing activities (4,771) (6,472) (8,216)
Cash Flows from Financing Activities      
Borrowings, net of issuance costs 4,632 2,879 958
Repayments of debt (4,033) (1,425) (710)
Financing portion of net cash paid in settlement of derivative instruments (35) (222) 0
Increase (decrease) in outstanding checks (23) 62 (13)
Dividends paid (553) (505) (274)
Repurchase of common stock (55) (45) (54)
Issuance of common stock, including tax benefit on share-based compensation awards 34 121 146
Distributions to noncontrolling interest owners (282) (216) (156)
Contributions from noncontrolling interest owners 0 0 2
Net cash provided by (used in) financing activities 220 1,675 623
Effect of Exchange Rate Changes on Cash (2) 2 (68)
Net Increase (Decrease) in Cash and Cash Equivalents (6,430) 3,671 1,227
Cash and Cash Equivalents at Beginning of Period 7,369 3,698 2,471
Cash and Cash Equivalents at End of Period 939 7,369 3,698
Subsidiary Equity Transactions [Member]      
Cash Flows from Financing Activities      
Sale of subsidiary units 187 1,026 724
Equity Component of 7.5% Tangible Equity Units [Member]      
Cash Flows from Financing Activities      
Sale of subsidiary units 348 0 0
Tronox Litigation [Member] | Judicial Ruling [Member]      
Changes in assets and liabilities      
Litigation-related contingent loss (5,210) 4,360 850
Excluding Certain International Locations [Member]      
Adjustments to reconcile net income (loss) to net cash provided by operating activities      
Deferred income taxes $ (3,152) $ (105) $ 90